| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |